Condition
Endobronchial Ultrasound
Total Trials
7
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 2 (1)
P 4 (1)
Trial Status
Completed4
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT05739331Recruiting
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
NCT05425836Not ApplicableCompletedPrimary
HFNC Versus SOT During EBUS
NCT04816981Not ApplicableCompleted
AI-EBUS-Elastography for LN Staging
NCT05696860Not ApplicableUnknown
Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation
NCT04718922Phase 4CompletedPrimary
Chlorhexidine Mouthrinse Before EBUS-TBNA
NCT03575715Not ApplicableUnknownPrimary
EBUS Image Features in the Diagnosis of PPLs
NCT02713191Phase 2Completed
Dexmedetomidine vs. Midazolam Sedation for Endobronchial Ultrasound
Showing all 7 trials